Theresa Matkovits

Theresa is a Biochemist and Molecular Biologist with more than 20 years of experience as a leader in global drug development and commercialization, with extensive expertise across a number of therapeutic areas including psychiatry, infectious disease, cardiovascular, and women’s health. She currently serves as the Chief Development Officer at Matinas Biopharma, leading the Global Development efforts for the company’s clinical-stage pipeline products. Prior to this role, Theresa has held roles as a Chief Operating Officer; Vice President and Innovation Leader; and several global leadership positions at ContraVir (now Hepion), NPS Pharmaceuticals; The Medicines Company; and Novartis. She is also currently a member of the Board of Directors for Appili Therapeutics.